USFDA further noted that the company's investigations of out-of-specification (OOS) results were inadequate because they lacked scientific rationale for root cause determinations.
from Health News | Latest Healthcare Sector & Healthcare Industry news, Information and Updates: ET HealthWorld : ETHealthworld.com https://ift.tt/Rz1mEpP
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment